A crucial element of regenerative healthcare and drug discovery lies in the ability to expand human stem cell groups to sufficient numbers for therapeutic purposes. Traditionally, constrained cell supply posed a significant hindrance to development in these fields. Consequently, considerable effort has been directed towards enhancing protocols for